Skip to main content
Caplight Logo









Sprout Pharmaceuticals, Inc.

Sprout Pharmaceuticals, Inc.

Private
Raleigh, North CarolinaHealthcare & Life Scienceshttps://www.sproutpharmaceuticals.com/

Last Round

VC Round

Sep 4, 2019

Est. Valuation

$1B

Total Funding Raised

$130M

Company Overview

Sprout Pharmaceuticals, Inc. is a pharmaceutical company that develops and markets treatments for women's sexual health, most notably the FDA-approved medication Addyi for the treatment of Hypoactive Sexual Desire Disorder (HSDD).

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Patient Engagement

Business Model

B2B2C

Customer Profile

Services & Consulting

AI Layer

Non-AI

Keywords

hypoactive sexual desire disorderHSDDfemale sexual healthflibanserinwomen's healthprescription medicationpink pillspecialty pharmaceuticalnon-hormonal treatmentpatient access programdirect-to-consumertelehealth pharmacy

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Sprout Pharmaceuticals, Inc. Comparables

Compare Sprout Pharmaceuticals, Inc. with similar companies based on industry and business-model similarity.

Sprout Pharmaceuticals, Inc. comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Cosette Pharmaceuticals, Inc.
80%
S1 Biopharma, Inc.
74%
Freya Pharma Solutions
71%

Sprout Pharmaceuticals, Inc. Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
VC RoundSep 4, 2019
DebtNov 6, 2017
M&AAug 20, 2015
Series CJun 8, 2015
Series BJul 11, 2014
Series A
Jun 25, 2013

Key People

Founding team and executive leadership

Cindy Eckert

CEO

Executive Team

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jan 29, 2026

    Attended the 2026 Oprah Daily Menopause O-wards.

  • Jan 29, 2026

    Product named 'Best Prescription for Low Libido' in Oprah Daily awards.

Sprout Pharmaceuticals, Inc. Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Sprout Pharmaceuticals, Inc. Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Sprout Pharmaceuticals, Inc.'s valuation, stock price, and market status.

Firmographic Details

HeadquartersRaleigh, North Carolina
Employee Range31
Year Founded2011
Last FundingSep 4, 2019

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.